What question did this study set out to answer?

To compare the effectiveness of a new 4 month regimen for drug-sensitive TB with the standard 6 month regimen.

P37 The effectiveness of a new short regimen for drug-sensitive TB: preliminary results

View Full Paper

Ask AI

Bookmark

Authors

A comparison shows a 4 month regimen with rifapentine improves outcomes in patients with drug-sensitive TB, suggesting potential for broader use.

To compare the effectiveness of a new 4 month regimen for drug-sensitive TB with the standard 6 month regimen.
Analyzed treatment of 92 TB patients with drug-sensitive strains.
Divided patients into two equal groups for comparison.
Main group received a 4 month regimen with rifapentine, isoniazid, pyrazinamide, and levofloxacin.
Control group followed the standard 6 month regimen.
Cumulative score at 8 weeks was 34.89 in the 4 month group and 25.56 in the control group.
Statistical significance was noted with P=0.019, indicating better outcomes for the 4 month regimen.

Guseva et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

A comparison shows a 4 month regimen with rifapentine improves outcomes in patients with drug-sensitive TB, suggesting potential for broader use.

To compare the effectiveness of a new 4 month regimen for drug-sensitive TB with the standard 6 month regimen.
Analyzed treatment of 92 TB patients with drug-sensitive strains.
Divided patients into two equal groups for comparison.
Main group received a 4 month regimen with rifapentine, isoniazid, pyrazinamide, and levofloxacin.
Control group followed the standard 6 month regimen.
Cumulative score at 8 weeks was 34.89 in the 4 month group and 25.56 in the control group.
Statistical significance was noted with P=0.019, indicating better outcomes for the 4 month regimen.

Guseva et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark